{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:06:56Z","timestamp":1771261616902,"version":"3.50.1"},"reference-count":64,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T00:00:00Z","timestamp":1488672000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">ACT<\/jats:styled-content> Genetic Service at The Canberra Hospital evaluates the genetic risk of individuals for inherited diseases, and provides counselling and genetic testing where appropriate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the current referral practice for patients with a personal and\/or family history of breast and\/or ovarian cancer, and to assess whether these referrals are made according to <jats:styled-content style=\"fixed-case\">eviQ<\/jats:styled-content> cancer referral guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective clinical audit of patients seen by the <jats:styled-content style=\"fixed-case\">ACT<\/jats:styled-content> Genetic Service for evaluation of genetic risk of breast and\/or ovarian cancer between 1 January 2013 and 30 June 2015. Statistical analysis included Chi\u2010squared and Poisson distribution tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 711 patients referred during the 30\u2010month period, 671 were seen by the service. The number of patients seen increased steadily over the time period, as did waiting times. The majority of referrals were made by general practitioners (403\/711; 57%) and oncologists (172\/711; 24%). Of note, 300 of 711 (42%) of all referrals made to the service during this time period did not meet <jats:styled-content style=\"fixed-case\">eviQ<\/jats:styled-content> referral guidelines. Patients who met guidelines for referral were more likely both to be offered genetic testing and to have a positive result.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Demand on the <jats:styled-content style=\"fixed-case\">ACT<\/jats:styled-content> Genetic Service increased over the time period assessed. As a significant proportion of patients did not meet <jats:styled-content style=\"fixed-case\">eviQ<\/jats:styled-content> cancer referral guidelines, it is worth reviewing the referral process in order to optimise utility of this limited resource.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.13357","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T06:32:43Z","timestamp":1482733963000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Breast and ovarian cancer referrals to the <scp>ACT<\/scp> Genetic Service: are we meeting guidelines?"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-7090","authenticated-orcid":false,"given":"Lucy","family":"Aitken","sequence":"first","affiliation":[{"name":"Australian National University  Canberra Australian Capital Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Warwick","sequence":"additional","affiliation":[{"name":"ACT Genetic Service The Canberra Hospital  Canberra Australian Capital Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Davis","sequence":"additional","affiliation":[{"name":"Australian National University  Canberra Australian Capital Territory Australia"},{"name":"Medical Oncology The Canberra Hospital  Canberra Australian Capital Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,5]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"World Health Organization. Cancer Country Profiles Australia 2014 [updated 2014; cited 2016 Jun 1]. Available from URL:http:\/\/www.who.int\/entity\/cancer\/country\u2010profiles\/en\/"},{"key":"#cr-split#-e_1_2_6_3_1.1","unstructured":"Cancer Council Australia. Understanding Breast Cancer 2014 [updated 2016 Aug 8"},{"key":"#cr-split#-e_1_2_6_3_1.2","unstructured":"cited 2016 Jul 15]. Available from URL:http:\/\/www.cancer.org.au\/about\u2010cancer\/types\u2010of\u2010cancer\/breast\u2010cancer.html"},{"key":"e_1_2_6_4_1","unstructured":"Australian Institute of Health and Welfare.Cancer in Australia: An Overview. Cancer Series No. 78. Cat. no. CAN 75. Canberra: AIHW; 2014."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.20.14.1"},{"key":"e_1_2_6_6_1","unstructured":"Australian Government: Cancer Australia. Familial Risk Assessment 2011 [cited 2016 Jul 3]. Available from URL:https:\/\/canceraustralia.gov.au\/clinical\u2010best\u2010practice\/gynaecological\u2010cancers\/familial\u2010risk\u2010assessment\u2010fra\u2010boc"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2007.00515.x"},{"key":"e_1_2_6_8_1","first-page":"1691","article-title":"Hereditary breast and ovarian cancers","volume":"54","author":"Carroll JC","year":"2008","journal-title":"Can Fam Physician"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181d38f2f"},{"key":"#cr-split#-e_1_2_6_10_1.1","unstructured":"eviQ Cancer Treatments Online. Genetic Testing for Heritable Mutations in the BRCA1 and BRCA2 Genes 2016 [updated 2016 Mar 3"},{"key":"#cr-split#-e_1_2_6_10_1.2","unstructured":"cited 2016 Apr 5]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/440\/id\/620\/Genetic+Testing+for+Heritable+Mutations+in+the+BRCA1+and+BRCA2+Genes.aspx"},{"key":"#cr-split#-e_1_2_6_11_1.1","unstructured":"eviQ Cancer Treatments Online. Cancer Genetics: Referral Guidelines for Breast Cancer Risk Assessment and Consideration of Genetic Testing 2014 [updated 2015 Oct 7"},{"key":"#cr-split#-e_1_2_6_11_1.2","unstructured":"cited 2015 Sep 29]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/105\/id\/1620\/Referral+Guidelines+for+Breast+Cancer+Risk+Assessment+and+Consideration+of+Genetic+Testing.aspx"},{"key":"#cr-split#-e_1_2_6_12_1.1","unstructured":"eviQ Cancer Treatments Online. Cancer Genetics: Referral Guidelines for Ovarian Cancer Risk Assessment and Consideration of Genetic Testing [updated 2016 Jul 25"},{"key":"#cr-split#-e_1_2_6_12_1.2","unstructured":"cited 2015 Sep 30]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/id\/1905\/Default.aspx?popup=1"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0529-1"},{"key":"#cr-split#-e_1_2_6_14_1.1","unstructured":"National Institutes of Health. BRCA1 and BRCA2: Cancer Risk and Genetic Testing 2015 [updated 2015 Apr 1"},{"key":"#cr-split#-e_1_2_6_14_1.2","unstructured":"cited 2016 Mar 1]. Available from URL:http:\/\/www.cancer.gov\/about\u2010cancer\/causes\u2010prevention\/genetics\/brca\u2010fact\u2010sheet"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1431"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209879"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","unstructured":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population\u2010based series of breast cancer cases.Br J Cancer2000; 83: 1301\u20138.","DOI":"10.1054\/bjoc.2000.1407"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3892\/or_00001031"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21536"},{"key":"#cr-split#-e_1_2_6_20_1.1","unstructured":"eviQ Cancer Treatments Online. Information for people and families with a faulty BRCA1 gene (mutation) 2015 [updated 2015 Jul 31"},{"key":"#cr-split#-e_1_2_6_20_1.2","unstructured":"cited 2016 Feb 25]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/441\/id\/764\/Information+for+people+and+families+with+a+faulty+BRCA1+gene+(mutation).aspx"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.18.1365"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.1066"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/375033"},{"key":"#cr-split#-e_1_2_6_24_1.1","unstructured":"eviQ Cancer Treatments Online. Information for people and families with a faulty BRCA2 gene (mutation) 2015 [updated 2015 Jul 31"},{"key":"#cr-split#-e_1_2_6_24_1.2","unstructured":"cited 2016 Feb 23]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/441\/id\/765\/Information+for+people+and+families+with+a+faulty+BRCA2+gene+(mutation).aspx"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2054"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr426"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1331"},{"key":"e_1_2_6_28_1","first-page":"1387","article-title":"Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression","volume":"34","author":"Kechagioglou P","year":"2014","journal-title":"Anticancer Res"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.01.010"},{"key":"#cr-split#-e_1_2_6_30_1.1","unstructured":"eviQ Cancer Treatments Online. Genetic Testing for the (3113G>A) Mutation in the PALB2 Gene 2015 [updated 2015 Oct 1"},{"key":"#cr-split#-e_1_2_6_30_1.2","unstructured":"cited 2016 Nov 12]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/440\/id\/1557\/Genetic+Testing+for+Heritable+Mutations+in+the+PALB2+Gene.aspx"},{"key":"#cr-split#-e_1_2_6_31_1.1","unstructured":"eviQ Cancer Treatments Online. Genetic Testing for the (c.7271T>G) Mutation in the ATM Gene 2016 [updated 2016 Jul 11"},{"key":"#cr-split#-e_1_2_6_31_1.2","unstructured":"cited 2016 Nov 9]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/440\/id\/1558\/Genetic+Testing+for+Heritable+Mutations+in+the+ATM+Gene.aspx"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9664-5"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2014.397"},{"key":"#cr-split#-e_1_2_6_34_1.1","unstructured":"eviQ Cancer Treatments Online. Risk Management for an Unaffected Female ATM (c.7271T>G) Mutation Carrier 2014 [updated 2016 Sep 28"},{"key":"#cr-split#-e_1_2_6_34_1.2","unstructured":"cited 2016 Nov 3]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/66\/id\/1610\/Risk+Management+for+a+Female+ATM++Mutation+Carrier.aspx"},{"key":"#cr-split#-e_1_2_6_35_1.1","unstructured":"eviQ Cancer Treatments Online. Risk Management for an Unaffected Female PALB2 Mutation Carrier 2014 [updated 2016 Sep 28"},{"key":"#cr-split#-e_1_2_6_35_1.2","unstructured":"cited 2016 Nov 2]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/66\/id\/1609\/Risk+Management+for+a+Female+PALB2+Mutation+Carrier+.aspx"},{"key":"#cr-split#-e_1_2_6_36_1.1","unstructured":"eviQ Cancer Treatments Online. Risk Management for Lynch Syndrome [updated 2016 Apr 15"},{"key":"#cr-split#-e_1_2_6_36_1.2","unstructured":"cited 2016 Jan 22]. Available from URL:https:\/\/www.eviq.org.au\/Protocol\/tabid\/66\/categoryid\/66\/id\/1410\/Risk+Management+for+Lynch+Syndrome.aspx"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1317"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2820"},{"key":"e_1_2_6_40_1","first-page":"29","article-title":"Tamoxifen for women at high risk of breast cancer","volume":"6","author":"Nazarali SA","year":"2014","journal-title":"Breast Cancer"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.8313"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.01065.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26166"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32643"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.09.027"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2879"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2011.01431.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02284.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-13-82"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-112"},{"key":"e_1_2_6_51_1","article-title":"In the wake of Angelina: managing a family history of breast cancer","volume":"43","author":"Dunlop B","year":"2014","journal-title":"Aust Fam Physician"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.423"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(01)00133-2"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.13357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.13357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:54:54Z","timestamp":1695509694000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.13357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/imj.13357"],"URL":"https:\/\/doi.org\/10.1111\/imj.13357","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"2016-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}